Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EpiCom
2023-507426-17-00Phase 4Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 4, open-label, single-arm trial of cannabidiol in tuberous sclerosis complex (TSC), sponsored by Jazz Pharmaceuticals plc. Started Nov 2024; status: completed.
02
Drugs
cannabidiol
03
Conditions
tuberous sclerosis complex (TSC)
Beyond the preview
Go deeper on 2023-507426-17-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-507426-17-00.